Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome.
about
Diarrheagenic Escherichia coliPathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infectionsSafety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coliIntracellular neutralization of shiga toxin 2 by an a subunit-specific human monoclonal antibody.Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome.Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndromeSaliva IgM and IgA are a sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome.Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease.Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany.Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestationsGenotypic and phenotypic diversity among induced, stx2-carrying bacteriophages from environmental Escherichia coli strainsBiodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice.Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.Shiga toxin-producing escherichia coli infections in Norway, 1992-2012: characterization of isolates and identification of risk factors for haemolytic uremic syndrome.Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct cultureAnalysis of the enterohemorrhagic Escherichia coli O157 DNA region containing lambdoid phage gene p and Shiga-like toxin structural genes.Isolation and characterization of sorbitol-fermenting Shiga toxin (Verocytotoxin)-producing Escherichia coli O157:H- strains in the Czech Republic.In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2.Selective Evolution of Ligands by Exponential Enrichment to Identify RNA Aptamers against Shiga Toxins.Characterization of a shiga toxin 2e-converting bacteriophage from an Escherichia coli strain of human origin.Detection of hemolysin variants of Shiga toxin-producing Escherichia coli by PCR and culture on vancomycin-cefixime-cefsulodin blood agar.Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.Real-time fluorescence PCR assays for detection and characterization of Shiga toxin, intimin, and enterohemolysin genes from Shiga toxin-producing Escherichia coli.Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains.Molecular analysis of H antigens reveals that human diarrheagenic Escherichia coli O26 strains that carry the eae gene belong to the H11 clonal complexSorbitol-fermenting Shiga toxin-producing Escherichia coli O157:H(-) strains: epidemiology, phenotypic and molecular characteristics, and microbiological diagnosis.Optimization of reverse transcriptase PCR to detect viable Shiga-toxin-producing Escherichia coli.Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variantsPCR-based detection and molecular characterization of shiga toxin-producing Escherichia coli strains in a routine microbiology laboratory over 16 yearsNorwegian sheep are an important reservoir for human-pathogenic Escherichia coli O26:H11.New Monoclonal Antibodies against a Novel Subtype of Shiga Toxin 1 Produced by Enterobacter cloacae and Their Use in Analysis of Human Serum.Molecular and antimicrobial susceptibility analyses distinguish clinical from bovine Escherichia coli O157 strains.A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine modelFirst-time isolation and characterization of a bacteriophage encoding the Shiga toxin 2c variant, which is globally spread in strains of Escherichia coli O157.Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli.A genomic island, termed high-pathogenicity island, is present in certain non-O157 Shiga toxin-producing Escherichia coli clonal lineages.Expression of hemin receptor molecule ChuA is influenced by RfaH in uropathogenic Escherichia coli strain 536Transduction of enteric Escherichia coli isolates with a derivative of Shiga toxin 2-encoding bacteriophage phi3538 isolated from Escherichia coli O157:H7.Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans
P2860
Q24533466-BCD50B23-B4D9-43FA-9A85-339E71104A5DQ24550740-08E74417-8121-4D07-AF46-5EBF9799D1EAQ24653814-55741FEC-0830-494E-9C26-72156168783AQ30481790-482277B0-AF63-4F24-90C3-06DE2DED3972Q33337454-E7C13002-60E5-43DA-B71D-72920B37444AQ33342197-54178F35-EF61-472D-8D0E-6C165F2968AEQ33343456-2E5FD6E2-97F7-4F28-9E90-E5549319D702Q33348352-7E066C19-AF60-4356-844A-A2187253B882Q33359875-56F5BD7A-5862-438E-840A-7A40EE5A68E6Q33363266-854D4D65-7163-4154-B6BA-AFB5609CFFD8Q33374948-EE7A93BD-3666-4D31-ADFE-17687BBE8E05Q33384593-F5D79B4B-3AC8-4DB8-A7F5-78E2039D1DD7Q33401560-6BA3F942-F95E-4072-AEC0-D7AC4FA03AC1Q33418526-B1D5177A-3B00-4D49-90CF-528134072EB3Q33425076-512278FA-AEBD-45CA-8DEE-E47370C643ABQ33497617-D33773F5-68C4-45D5-B0EC-87F38C5F14A0Q33498080-B8969286-CD6D-4405-A101-1A120A9892F2Q33502935-E4B0527F-6CE4-42B4-8A4C-884B7BCE4E54Q33545441-010AAA1D-AA62-41CB-89D7-DAE2F00C6928Q33563140-5EDF2CF2-BB23-432A-9C21-D2A235E435B0Q33596611-CD601081-2571-4159-8958-5576EDA710A2Q33714771-3BC2D594-D12F-4108-87C2-94E35D921574Q33946874-D9CF21DB-8CCA-43D2-A00C-B69B6282B4D8Q33963284-8094184F-2EE6-4F6D-A03C-8C209267DABBQ33967359-B4D71338-1ABA-4A7B-A89D-1D2EA2A3A257Q33968866-B7684797-6C1A-4836-84FA-6033506C3454Q33972443-4C35EB1B-0ED3-4227-A70A-7A79D381A995Q34099880-DE141D5C-F3BD-478E-A5E4-D30C3DCD19A3Q35012815-125FF367-7C75-4089-A875-0FDE7D18CB6BQ35035686-A9264686-E98E-4424-AE42-DA04347D099DQ36018107-DB53014F-E129-4E38-8B9C-B96293FCDC74Q36891324-5324F623-E9D2-40ED-9DEC-17B0A2C646C8Q36971116-B8002012-E64D-4838-A0FF-73C9A59D5C21Q37190873-1C941B99-6F7D-4A51-ADE9-5C46707FB1C8Q37624022-449B5F3D-25F1-45A3-8418-345812ADB0EDQ39446323-1957845A-24FE-4F4B-92E7-7BC8173EBA00Q39512826-EADA59FF-CEDE-4088-AF5D-FAFCBFAA2FC5Q39519046-47BE9CBB-6F64-4261-822A-8E230C7C503CQ39527622-17CDA8A0-D7CB-43C5-8AAA-910ED3E3FB29Q39697637-06FBB2CB-300D-4BC6-9CB6-0675B5EEA52E
P2860
Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome.
description
1994 nî lūn-bûn
@nan
1994 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Variants of Shiga-like toxin I ...... h haemolytic uraemic syndrome.
@ast
Variants of Shiga-like toxin I ...... h haemolytic uraemic syndrome.
@en
type
label
Variants of Shiga-like toxin I ...... h haemolytic uraemic syndrome.
@ast
Variants of Shiga-like toxin I ...... h haemolytic uraemic syndrome.
@en
prefLabel
Variants of Shiga-like toxin I ...... h haemolytic uraemic syndrome.
@ast
Variants of Shiga-like toxin I ...... h haemolytic uraemic syndrome.
@en
P2093
P1476
Variants of Shiga-like toxin I ...... h haemolytic uraemic syndrome.
@en
P2093
P304
P356
10.1099/00222615-40-5-338
P577
1994-05-01T00:00:00Z